awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37052387-38703F7F-B2CA-4E3E-B4A1-6FD11D9F5147
Q37052387-38703F7F-B2CA-4E3E-B4A1-6FD11D9F5147
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37052387-38703F7F-B2CA-4E3E-B4A1-6FD11D9F5147
Subgroup Analyses from a Phase 3, Open-Label, Randomized Study of Eribulin Mesylate Versus Capecitabine in Pretreated Patients with Advanced or Metastatic Breast Cancer
P2860
Q37052387-38703F7F-B2CA-4E3E-B4A1-6FD11D9F5147
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37052387-38703F7F-B2CA-4E3E-B4A1-6FD11D9F5147
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
574dd142e2e2686f9271200754c2a0003b606067
P2860
Eribulin mesylate reduces tumor microenvironment abnormality by vascular remodeling in preclinical human breast cancer models